{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T09:31:51Z","timestamp":1792575111781,"version":"4.5.0"},"reference-count":37,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,1,8]],"date-time":"2024-01-08T00:00:00Z","timestamp":1704672000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"abstract":"<jats:p>This study identified the metabolic biomarkers for different clinical phases of bipolar disorder (BD) through metabolomics. BD patients were divided into three groups: patients with BD and depressive episodes (BE, <jats:italic>n<\/jats:italic> = 59), patients with BD and mania\/hypomania episodes (BH, <jats:italic>n<\/jats:italic> = 16), patients with BD and mixed episodes (BM, <jats:italic>n<\/jats:italic> = 10), and healthy controls (HC, <jats:italic>n<\/jats:italic> = 10). Serum from participants was collected for metabolomic sequencing, biomarkers from each group were screened separately by partial least squares analysis, and metabolic pathways connected to the biomarkers were identified. Compared with the controls, 3-D-hydroxyacetic acid and N-acetyl-glycoprotein showed significant differences in the BE, BH, and BM groups. This study suggests that different clinical types of BD share the same metabolic pathways, such as pyruvate, glycolysis\/gluconeogenesis, and ketone body metabolisms. In particular, abnormal glycine, serine, and threonine metabolism was specific to BM; \u03b2-glucose, glycerol, lipids, lactate, and acetoacetate metabolites were specific to depressive episodes; the guanidine acetic acid metabolites specific to BH; and the acetic and ascorbic acids were metabolites specific to manic and BM. We screened potential biomarkers for different clinical phases of BD, which aids in BD typing and provides a theoretical basis for exploring the molecular mechanisms of BD.<\/jats:p>","DOI":"10.3389\/fpsyt.2023.1319870","type":"journal-article","created":{"date-parts":[[2024,1,8]],"date-time":"2024-01-08T05:35:07Z","timestamp":1704692107000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["Comparing the metabolic pathways of different clinical phases of bipolar disorder through metabolomics studies"],"prefix":"10.3389","volume":"14","author":[{"given":"Qin","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiao","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao Li","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,1,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1111\/acps.12003","article-title":"Occupational disability in bipolar disorder: analysis of predictors of being on severe disablement benefit (PREBIS study data)","volume":"127","author":"Grande","year":"2013","journal-title":"Acta Psychiatr Scand."},{"key":"B2","doi-asserted-by":"publisher","first-page":"363","DOI":"10.202207\/article.29956510","article-title":"Bipolar disorder: clinical overview","volume":"39","author":"Muller","year":"2016","journal-title":"Med Monatsschr Pharm."},{"key":"B3","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1192\/bjpo.bp.115.002402","article-title":"Days out of role due to common physical and mental conditions in Portugal: results from the WHO World Mental Health Survey","volume":"3","author":"Cardoso","year":"2017","journal-title":"BJPsych Open."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1016\/S0140-6736(15)00241-X","article-title":"Bipolar disorder","volume":"387","author":"Grande","year":"2016","journal-title":"Lancet."},{"key":"B5","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.jad.2014.09.026","article-title":"The prevalence and illness characteristics of DSM-5-defined \u201cmixed feature specifier\u201d in adults with major depressive disorder and bipolar disorder: results from the International Mood Disorders Collaborative Project","volume":"172","author":"McIntyre","year":"2015","journal-title":"J Affect Disord."},{"key":"B6","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/j.1399-5618.2009.00706.x","article-title":"The history of lithium therapy","volume":"11","author":"Shorter","year":"2009","journal-title":"Bipolar Disord."},{"key":"B7","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.jad.2015.10.026","article-title":"Decreased serum zinc concentration during depressive episode in patients with bipolar disorder","volume":"190","author":"Siwek","year":"2016","journal-title":"J Affect Disord."},{"key":"B8","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1192\/bjp.2018.144","article-title":"Neurotrophins, cytokines and oxidative stress mediators and mood state in bipolar disorder: a systematic review and meta-analysis","volume":"213","author":"Rowland","year":"2018","journal-title":"Bipolar Disord"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1016\/j.pnpbp.2009.07.027","article-title":"The potential use of biomarkers as an adjunctive tool for staging bipolar disorder","volume":"33","author":"Kapczinski","year":"2009","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry."},{"key":"B10","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1093\/ijnp\/pyy018","article-title":"Mitochondrial agents for bipolar disorder","volume":"21","author":"Pereira","year":"2018","journal-title":"Int J Neuropsychopharmacol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"113880","DOI":"10.1016\/j.psychres.2021.113880","article-title":"A plasma metabolomics study suggests alteration of multiple metabolic pathways in patients with bipolar disorder","volume":"299","author":"Wei","year":"2021","journal-title":"Psychiatry Res."},{"key":"B12","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1017\/S0033291719000400","article-title":"Metabolic dysfunctions in the kynurenine pathway, noradrenergic and purine metabolism in schizophrenia and bipolar disorders","volume":"50","author":"Steen","year":"2020","journal-title":"Psychol Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.jad.2018.10.360","article-title":"Impaired glucose metabolism in bipolar patients and response to mood stabilizer treatments","volume":"245","author":"Steardo L","year":"2019","journal-title":"J Affect Disord."},{"key":"B14","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.copbio.2014.08.006","article-title":"High-throughput discovery metabolomics","volume":"31","author":"Fuhrer","year":"2015","journal-title":"Curr Opin Biotechnol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"2692","DOI":"10.1038\/nprot.2007.376","article-title":"Metabolic profiling, metabolomic and metabonomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extracts","volume":"2","author":"Beckonert","year":"2007","journal-title":"Nat Protoc."},{"key":"B16","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1080\/15622975.2017.1384850","article-title":"The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: acute and long-term treatment of mixed states in bipolar disorder","volume":"19","author":"Grunze","year":"2018","journal-title":"World J Biol Psychiatry."},{"key":"B17","doi-asserted-by":"publisher","first-page":"W388","DOI":"10.1093\/nar\/gkab382","article-title":"MetaboAnalyst 50: narrowing the gap between raw spectra and functional insights","volume":"49","author":"Pang","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"B18","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1186\/s12888-022-04079-8","article-title":"Metabolomic biomarkers related to non-suicidal self-injury in patients with bipolar disorder","volume":"22","author":"Guo","year":"2022","journal-title":"BMC Psychiatry."},{"key":"B19","doi-asserted-by":"publisher","first-page":"569612","DOI":"10.3389\/fpsyt.2020.569612","article-title":"Metabolic profiling in bipolar disorder patients during depressive episodes","volume":"11","author":"Ren","year":"2020","journal-title":"Front Psychiatry."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.18632\/aging.101805","article-title":"Urinary metabolite signature in bipolar disorder patients during depressive episode","volume":"11","author":"Chen","year":"2019","journal-title":"Aging."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1517\/14728222.2014.940893","article-title":"Targeting mitochondrially mediated plasticity to develop improved therapeutics for bipolar disorder","volume":"18","author":"de Sousa","year":"2014","journal-title":"Expert Opin Ther Targets."},{"key":"B22","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.psychres.2014.04.005","article-title":"An updated meta-analysis of oxidative stress markers in bipolar disorder","volume":"218","author":"Brown","year":"2014","journal-title":"Psychiatry Res."},{"key":"B23","doi-asserted-by":"publisher","first-page":"5855","DOI":"10.1038\/srep05855","article-title":"Combined application of NMR- and GC-MS-based metabonomics yields a superior urinary biomarker panel for bipolar disorder","volume":"4","author":"Chen","year":"2014","journal-title":"Sci Rep"},{"key":"B24","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1007\/s11306-013-0508-y","article-title":"Novel urinary biomarkers for diagnosing bipolar disorder","volume":"9","author":"Zheng","year":"2013","journal-title":"Metabolomics."},{"key":"B25","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.dsx.2015.04.004","article-title":"Levels of triglycerides, cholesterol, LDL, HDL and glucose in patients with schizophrenia, unipolar depression and bipolar disorder","volume":"9","author":"Wysokinski","year":"2015","journal-title":"Diabetes Metab Syndr."},{"key":"B26","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s40345-017-0088-2","article-title":"1H-NMR, 1H-NMR T2-edited, and 2D-NMR in bipolar disorder metabolic profiling","volume":"5","author":"Sethi","year":"2017","journal-title":"Int J Bipolar Disord."},{"key":"B27","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1111\/acps.13278","article-title":"Elevated lipids are associated with reduced regional brain structure in youth with bipolar disorder","volume":"143","author":"Kennedy","year":"2021","journal-title":"Acta Psychiatr Scand."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.17179\/excli2020-2763","article-title":"Assessment of trimethylamine-N-oxide at the blood-cerebrospinal fluid barrier: Results from 290 lumbar punctures","volume":"19","author":"Enko","year":"2020","journal-title":"EXCLI J."},{"key":"B29","doi-asserted-by":"publisher","first-page":"e12768","DOI":"10.1111\/acel.12768","article-title":"Trimethylamine-N-oxide promotes brain aging and cognitive impairment in mice","volume":"17","author":"Li","year":"2018","journal-title":"Aging Cell."},{"key":"B30","doi-asserted-by":"publisher","first-page":"7897240","DOI":"10.1155\/2020\/7897240","article-title":"Sex-specific associations of trimethylamine-N-oxide and zonulin with signs of depression in carbohydrate malabsorbers and nonmalabsorbers","volume":"2020","author":"Meinitzer","year":"2020","journal-title":"Dis Mark."},{"key":"B31","doi-asserted-by":"publisher","first-page":"2506","DOI":"10.1007\/s11064-019-02868-4","article-title":"Higher circulating trimethylamine N-oxide sensitizes sevoflurane-induced cognitive dysfunction in aged rats probably by downregulating hippocampal methionine sulfoxide reductase A","volume":"44","author":"Zhao","year":"2019","journal-title":"Neurochem Res."},{"key":"B32","doi-asserted-by":"publisher","first-page":"111902","DOI":"10.1016\/j.bbr.2019.111902","article-title":"The presence of elevated circulating trimethylamine N-oxide exaggerates postoperative cognitive dysfunction in aged rats","volume":"368","author":"Meng","year":"2019","journal-title":"Behav Brain Res."},{"key":"B33","doi-asserted-by":"publisher","first-page":"108563","DOI":"10.1016\/j.neuropharm.2021.108563","article-title":"Exogenous microbiota-derived metabolite trimethylamine N-oxide treatment alters social behaviors: involvement of hippocampal metabolic adaptation","volume":"191","author":"Luo","year":"2021","journal-title":"Neuropharmacology."},{"key":"B34","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1126\/science.aba3683","article-title":"High-fat diet-induced colonocyte dysfunction escalates microbiota-derived trimethylamine N-oxide","volume":"373","author":"Yoo","year":"2021","journal-title":"Science."},{"key":"B35","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3390\/nu14010075","article-title":"Safety of dietary guanidinoacetic acid: a villain of a good guy?","author":"Ostojic","year":"2021","journal-title":"Nutrients"},{"key":"B36","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1038\/s41586-020-2609-x","article-title":"Serine restriction alters sphingolipid diversity to constrain tumour growth","volume":"586","author":"Muthusamy","year":"2020","journal-title":"Nature."},{"key":"B37","doi-asserted-by":"publisher","first-page":"110249","DOI":"10.1016\/j.biopha.2020.110249","article-title":"The mood stabilizing properties of AF3581, a novel potent GSK-3beta inhibitor","volume":"128","author":"Capurro","year":"2020","journal-title":"Biomed Pharmacother."}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2023.1319870\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,8]],"date-time":"2024-01-08T05:35:11Z","timestamp":1704692111000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2023.1319870\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,8]]},"references-count":37,"alternative-id":["10.3389\/fpsyt.2023.1319870"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2023.1319870","relation":{},"ISSN":["1664-0640"],"issn-type":[{"value":"1664-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,8]]},"article-number":"1319870"}}